Immunohistochemical studies on prostate cancer tissues have demonstrated Dicer overexpression in prostatic intraepithelial neoplasia (PIN) and in over 80% of prostate adenocarcinomas, indicating its potential role as a biomarker for early detection and progression monitoring (Chiosea et al., 2006). Here, DICER1 is linked to prostate cancer.